Latest Breaking News On - Cosmo biopharma - Page 1 : comparemela.com

In older patients with inflammatory bowel disease, adverse event rates were comparable between those treated with Stelara and those who received placebo, according to a recent analysis. “All of us who take care of patients with IBD are taking care of patients who are getting older and we are confronted with having to make choices of different medications, including biologic therapy, in

United statesMariat abreuCosmo biopharmaLandos biopharmaLas vegasEli lillyMelissa fosterGilead sciencesColitis centerCornerstone healthBoehringer ingelheimUniversity of miami miller school medicineScientific meetingFocus medical communicationsPrometheus biosciencesMiami miller school